Moleculin Reports First Quarter 2021 Financial Results and Provides Programs Update
- Wednesday, May 12, 2021, 7:01
- Finance
- Add a comment
HOUSTON, May 12, 2021 /PRNewswire/ — Moleculin Biotech, Inc., (Nasdaq: MBRX) (Moleculin or the Company), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and viruses, today announced its financial results for the quarter…
About the Author
adminasapcorp has written 41811 stories on this site.